// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1671 Abstracts

The Impact of Transplant Hospital Organ Procurement on Medicare Cost Report Reimbursement

E. Y. Zavala - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SAT-LB055 Using Fluidics to Model the Genomic Evolution of Metastatic Breast Cancer

Charles Byrne - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Ambulatory Electronic Health Record Referrals: Center for Tobacco Control (CTC)

P. A. Folan - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

CMET-21. A PHASE IB STUDY OF PROTON CRANIOSPINAL IRRADIATION FOR THE TREATMENT OF SOLID TUMOR LEPTOMENINGEAL METASTASES

Anna Piotrowski - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Leptomeningeal Metastasis

N/A

Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine

I.S.Batth - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Methadone hydrochloride

4 Co-Crystal of Tramadol-Celecoxib: Efficacy and Safety Results from a Dose-Finding, Randomized, Double-blind, Multicenter, Phase II Clinical Trial in Patients With Moderate-To-Severe Acute Pain Due To an Oral Surgical Procedure

Jose Lopez Cendrun - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

E58425

3 The Unique Physiochemical Profile of Co-Crystal of Tramadol-Celecoxib Optimizes Pharmacokinetic and Pharmacodynamic Synchronization: Structural Properties, Differential Dissolution Behavior and Pharmacokinetic Parameters

Carmen Almansa - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

E58425

2 A Co-Crystal of Tramadol-Celecoxib in a 1:1 Molecular Ratio Produced Synergistic Antinociceptive Effects in a Postoperative Pain Model in Rats

Manuel Merlos - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Allodynia

Tramadol/Acetaminophen

PD15-12 BLADDER CANCER CIRCULATING TUMOR CELL CONCENTRATION FLUCTUATES IN THE ABSENCE OF SYSTEMIC THERAPY OR SURGERY

Stephanie Glavaris - American Urological Association (AUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MP40-20 NOVEL CIRCULATING TUMOR CELLS BLOOD ASSAY FOR THE CLARIFICATION OF 4-10 NG/ML PSA RESULTS ASSESSED IN A PROSPECTIVE CLINICAL STUDY

See-Tong Pang - American Urological Association (AUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

MP40

MP58-05 THE LONG-TERM PROGNOSTIC VALUE OF SURVIVIN EXPRESSING CIRCULATING TUMOR CELLS IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Gian Maria Busetto - American Urological Association (AUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MP88-05 CLINICAL SIGNIFICANCE OF PHENOTYPING AND KARYOTYPING OF DETECTING CIRCULATING TUMOR CELLS IN RENAL CELL CARCINOMA USING SUBTRACTION ENRICHMENT AND IMMUNOSTAINING-FLUORESCENCE IN SITU HYBRIDIZATION (SET-IFISH)

Mingxin Zhang - American Urological Association (AUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MP87-03 TARGETED GENE EXPRESSION PROFILING WITHIN CIRCULATING TUMOR CELLS IN MCRPC

Udit Singhal - American Urological Association (AUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Single-cell technologies in development and disease with a special emphasis on endocrine systems

Karine Rizzoti - European Congress of Endocrinology (ECE) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Methadone hydrochloride

Angiographic guided PCI of ACS causing culprit lesions - Just a gamble?

M Riedel - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

PDTM-24. PILOT STUDY OF CIRCULATING TUMOR CELLS IN PEDIATRIC HIGH GRADE BRAIN TUMORS

Izhar Batth - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

EXTH-39. DETECTION, MOLECULAR PROFILING AND CULTURE OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) IN MELANOMA TO IMPROVE DIAGNOSIS AND TREATMENT STRATEGIES

Keiran Smalley - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Ceritinib

CMET-27. OUTCOMES OF LUNG CANCER PATIENTS WITH LEPTOMENINGEAL METASTASES IN THE TARGETED THERAPY ERA

Kathryn Nevel - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

- Molecular profiling of gastrointestinal cancer

P.Apostolou - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

ALTERATION OF METASTATIC BEHAVIOR BY SHRNA MEDIATED KNOCKDOWN (KD) OF CHD1 IN HUMAN PROSTATE XENOGRAFT TUMORS AND CLINICAL OUTCOME OF PATIENTS WITH CHD1 DELETION

Su Jung Oh - American Urological Association (AUA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved